menu
    • menu
    [{"orgOrder":0,"company":"Jeeva clinical Trials","sponsor":"Redwood Scientific Technologies Inc","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation","therapeuticArea":"Psychiatry\/Psychology","highestDevelopmentStatus":"Phase IV","country":"U.S.A","productType":"Small molecule","productStatus":"Approved","date":"February 2024","year":"2024","type":"Agreement","leadProduct":"Cytisine","moa":"","url1":"","url2":"","graph1":"Psychiatry\/Psychology","graph2":"Phase IV","graph3":"Jeeva clinical Trials","amount2":0,"therapeuticAreaNew":"Psychiatry\/Psychology","highestDevelopmentStatusNew":"Phase IV","highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Psychiatry","productSubType":"","amount2New":0,"dosageForm":"Strip","sponsorNew":"Jeeva clinical Trials \/ Redwood Scientific Technologies Inc","highestDevelopmentStatusID":"11","companyTruncated":"Jeeva clin.."}]

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Jeeva clinical Trials

                            Country arrow
                            26th North American ISSX
                            Not Confirmed

                            Jeeva clinical Trials

                            Country arrow
                            26th North American ISSX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cytisine

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase IV

                            Partner/Sponsor/Collaborator : Redwood Scientific Technologies Inc

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectivene...

                            Details : The agreement aims to launch a clinical effectiveness study of its TBX-Free oral strips (cytisine) products, acts similarly to nicotine where it can stimulate receptors in the brain, for smoking and e-cig...

                            Product Name : TBX-FREE

                            Product Type : Small molecule

                            Upfront Cash : Undisclosed

                            February 06, 2024

                            Lead Product(s) : Cytisine

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase IV

                            Partner/Sponsor/Collaborator : Redwood Scientific Technologies Inc

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Otsuka Pharmaceutical

                            Japan arrow
                            26th North American ISSX
                            Not Confirmed

                            Otsuka Pharmaceutical

                            Japan arrow
                            26th North American ISSX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Brexpiprazole

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase IV

                            Partner/Sponsor/Collaborator : H. Lundbeck AS

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            Otsuka And Lundbeck Generate Exploratory Data In Major Depressive Disorder Based On Patient Feedba...

                            Details : One of co-primary endpoints of study on adjunctive Rexulti (brexpiprazole) in adults with MDD and inadequate response to ADT was new exploratory outcome focusing on positive health aspects across emotiona...

                            Product Name : Rexulti

                            Product Type : Small molecule

                            Upfront Cash : Not Applicable

                            September 29, 2022

                            Lead Product(s) : Brexpiprazole

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase IV

                            Partner/Sponsor/Collaborator : H. Lundbeck AS

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth